| 000 | 01806 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516020648.0 | ||
| 264 | 0 | _c20110809 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/j.1440-1746.2011.06623.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTong, Myron John | |
| 245 | 0 | 0 |
_aEvaluation of current treatment recommendations for chronic hepatitis B: a 2011 update. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cMay 2011 |
||
| 300 |
_a829-35 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aCalifornia |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xmortality |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDNA, Viral _xblood |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xmortality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aSerum Albumin _xanalysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHsu, Leeyen | |
| 700 | 1 | _aChang, Patrick W | |
| 700 | 1 | _aBlatt, Lawrence Mitchell | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 26 _gno. 5 _gp. 829-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1746.2011.06623.x _zAvailable from publisher's website |
| 999 |
_c20499765 _d20499765 |
||